Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Hercules Technology Growth Capital (HTGC)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]

Price Performance

See More
Period Period Low Period High Performance
1-Month
13.20 +3.03%
on 07/18/18
13.70 -0.73%
on 08/03/18
+0.42 (+3.19%)
since 07/17/18
3-Month
12.07 +12.68%
on 06/12/18
13.70 -0.73%
on 08/03/18
+1.13 (+9.06%)
since 05/17/18
52-Week
11.55 +17.75%
on 03/02/18
13.97 -2.65%
on 11/09/17
+0.92 (+7.26%)
since 08/17/17

Most Recent Stories

More News
Consolidated Research: 2018 Summary Expectations for HCA Healthcare, The AES, Hercules Capital, Carrizo Oil & Gas, Callon Petroleum, and Ultra Clean -- Fundamental Analysis, Key Performance Indications

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of HCA Healthcare, Inc. (NYSE:HCA),...

HCA : 131.57 (+1.98%)
HTGC : 13.60 (unch)
CPE : 10.75 (+1.90%)
UCTT : 13.68 (+3.56%)
CRZO : 22.75 (-0.04%)
AES : 13.94 (+0.50%)
Hercules Capital (HTGC) Q2 Earnings Beat on Higher Revenues

Hercules Capital's (HTGC) Q2 earnings reflect strong fundamentals and higher loan origination volume.

TCPC : 14.80 (-0.27%)
FSIC : 7.50 (-1.32%)
HTGC : 13.60 (unch)
GARS : 8.42 (-0.06%)
Hercules Capital Reaches $8.0 Billion Milestone in Total Debt Commitments Since 2003

Hercules Capital, Inc. (NYSE: HTGC) ("Hercules" or the "Company"), the leading specialty financing provider to innovative venture growth stage companies backed by leading venture capital...

HTGC : 13.60 (unch)
HTGX : 25.22 (unch)
HCXZ : 24.54 (-0.04%)
Hercules Technology (HTGC) Q2 Earnings and Revenues Surpass Estimates

Hercules Tech (HTGC) delivered earnings and revenue surprises of 3.57% and 2.51%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?

HTGC : 13.60 (unch)
Hercules Capital Announces Second Quarter 2018 Financial Results and Quarterly Distribution of $0.31 per Share

--Surpasses $8.0 Billion Mark in Total Debt Commitments since Inception in December 2003

WFC : 58.86 (+0.34%)
EIDX : 18.15 (+6.45%)
HTGC : 13.60 (unch)
HTGX : 25.22 (unch)
HCXZ : 24.54 (-0.04%)
FSCT : 32.81 (+0.34%)
Moody's (MCO) Beats on Q2 Earnings & Revenues, Affirms View

Moody's (MCO) Q2 results reflect strong segmental performance and revenue growth.

LC : 3.79 (-1.04%)
MCO : 171.50 (-0.04%)
HTGC : 13.60 (unch)
ARCC : 17.35 (-0.23%)
Hercules Announces Date for Release of Second Quarter 2018 Financial Results and Conference Call

Hercules Capital, Inc. (NYSE: HTGC) ("Hercules" or the "Company"), the leading specialty finance company to innovative, venture growth, pre-IPO and M&A stage companies backed by leading...

HTGC : 13.60 (unch)
HTGX : 25.22 (unch)
HCXZ : 24.54 (-0.04%)
Hercules Capital Proudly Announces Eight Portfolio Companies Have Completed or Announced an IPO or M&A Liquidity Event Year-to-Date 2018

Hercules Capital, Inc. (NYSE: HTGC) ("Hercules" or the "Company"), the leading specialty financing provider to innovative venture growth stage companies backed by leading venture capital...

ITEK : 3.04 (-5.00%)
EIDX : 18.15 (+6.45%)
EVFM : 2.16 (-0.46%)
HTGC : 13.60 (unch)
RCKT : 20.02 (+0.65%)
HTGX : 25.22 (unch)
HCXZ : 24.54 (-0.04%)
FSCT : 32.81 (+0.34%)
Merrimack Secures $25 Million Debt Facility with Hercules Capital

CAMBRIDGE, Mass. , July 2, 2018 /PRNewswire/ -- Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK), a clinical-stage oncology company focused on biomarker-defined cancers, today announced the closing...

HTGC : 13.60 (unch)
MACK : 5.27 (+2.93%)
Merrimack Secures $25 Million Debt Facility with Hercules Capital

Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK), a clinical-stage oncology company focused on biomarker-defined cancers, today announced the closing of a $25 million term loan with Hercules Capital (NYSE:...

HTGC : 13.60 (unch)
MACK : 5.27 (+2.93%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 64% Buy with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

See More Share

HTGC Dividends

Date Value
08/10/18 $0.3100
05/11/18 $0.3100
03/02/18 $0.3100
11/10/17 $0.3100
08/10/17 $0.3100
05/11/17 $0.3100
03/02/17 $0.3100
11/09/16 $0.3100
Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar